- Clinical trials are research studies testing whether a new treatment is safe and effective; they are not guaranteed therapy.
- Trials study both wet and dry age-related macular degeneration (AMD), including drugs, injections, gene therapies, and devices.
- ClinicalTrials.gov is the main US registry for finding AMD studies.
- Informed consent means full information, the chance to ask questions, and the right to withdraw at any time.
- Inclusion and exclusion criteria decide who can join a given trial.
- Talk with your ophthalmologist or retina specialist before considering a trial, and never stop current treatment on your own to qualify.
Age-related macular degeneration (AMD) is a leading cause of vision loss in older adults, affecting the central part of the retina. Research is active across both the “dry” (atrophic) and “wet” (neovascular) forms, including new drugs, eye injections, gene therapies, implantable devices, and nutritional approaches. For some people, a clinical trial can be a way to access investigational treatments while contributing to research, but trials are research studies, not guaranteed therapy. This guide explains how AMD clinical trials work, what the phases mean, how to find studies, and what informed consent involves, so you can prepare a good conversation with your eye doctor.
What a clinical trial is
A clinical trial is a research study that tests a medical approach, such as a new medication, injection, gene therapy, or device, in people. The purpose is to answer specific questions: Is it safe? What dose or approach works best? Does it help more than existing options or a placebo/sham procedure? Because those answers are still being worked out, participation involves uncertainty. Participants may benefit, but benefit is never guaranteed and is not the study’s only goal.
For macular degeneration specifically, trials may test new anti-VEGF injections for wet AMD, complement-targeting therapies for dry AMD, longer-acting delivery systems, gene therapies, retinal implants, or nutritional and lifestyle interventions.
The phases of trials
New drugs and biologics generally move through phases, each asking a different question.
| Phase | Main question | Typical scope |
|---|---|---|
| Phase 1 | Is it safe, and what dose is tolerable? | Small group of participants |
| Phase 2 | Does it appear to work, and what are the side effects? | Larger group |
| Phase 3 | Is it effective compared with standard care or placebo/sham? | Large groups, often multiple sites |
| Phase 4 | What are the longer-term effects after approval? | Post-approval monitoring |
Many trials use randomization and a control group, and some are “blinded.” In eye trials, a comparison may involve a sham procedure rather than a placebo pill. These designs improve the reliability of results but mean you may not receive the new treatment.
How to search for AMD trials
The main US resource is ClinicalTrials.gov, a registry maintained by the National Institutes of Health that lists clinical studies worldwide. You can search by condition (such as “macular degeneration,” “wet AMD,” or “dry AMD”), location, and recruitment status. Each listing describes the purpose, eligibility criteria, locations, and contacts. The National Eye Institute (NEI) also shares information about vision research.
Academic eye centers and vision advocacy organizations may list opportunities as well. Read eligibility rules closely: inclusion criteria (characteristics you must have) and exclusion criteria (things that would keep you out), which often include AMD type and stage, age, prior treatments, and other conditions. For general context, our wellness guides take an evidence-first approach, and our overview of supplements studied for eye and brain health covers what the evidence does and does not show.
Informed consent and your rights
Before joining any trial, you go through informed consent. The research team must explain the study’s purpose, procedures, potential risks and benefits, alternatives, and what is expected of you, in language you can understand, and give you time to ask questions. Key protections include:
- Participation is voluntary, and declining will not affect your regular care.
- You can withdraw at any time, for any reason.
- Trials are reviewed by an independent ethics board (an Institutional Review Board).
- You should understand any costs, travel, time commitment, and what happens when the study ends.
Consent is an ongoing conversation, not just a signature. The same participant protections apply across conditions, as in our guide to clinical trials for COPD.
Talk with your eye specialist first
A trial is a medical decision, so involve the ophthalmologist or retina specialist who manages your AMD. They can help you weigh whether a study fits your situation, what the realistic pros and cons are, and how it interacts with your current treatment. Never stop or delay your existing AMD treatment, such as scheduled anti-VEGF injections, on your own to qualify for a trial; missed treatment can risk vision. Let your care team and the research team coordinate any changes safely.
Frequently asked questions
Will a trial restore my vision? No trial can promise that. Trials test whether treatments are safe and effective; benefit is possible but not guaranteed, and some studies aim to slow progression rather than reverse it.
Where do I find AMD trials? ClinicalTrials.gov is the main US registry; the National Eye Institute is another resource. Academic eye centers may also list studies.
Might I get a sham procedure? In some trials, yes. Randomized, masked designs may assign a comparison or sham group, which the consent process explains.
Do I have to pay? Study treatment is often provided, but costs vary. Ask about expenses, travel, and coverage before enrolling.
Can I leave after starting? Yes. Participation is voluntary, and you can withdraw at any time without losing access to your standard care.
Should I skip an injection to qualify? Never on your own. Any change must be guided by your eye specialist and the research team.
This article is for general education and is not medical advice. Supplements and therapies affect people differently and can interact with medications or conditions. Talk to your doctor, pharmacist, or a licensed clinician before making changes to your health routine.
Sources
- ClinicalTrials.gov — US registry of clinical studies and how to search it
- National Eye Institute (NEI) — macular degeneration and vision research information
- National Institutes of Health (NIH) — basics of clinical trials and participant protections
- U.S. Food and Drug Administration (FDA) — clinical trial phases and drug development
- MedlinePlus — clinical trials and macular degeneration overviews